ArticleJournal of clinical laboratory analysis2026
Assessment of Dried Plasma Spots (DPS) as an Appropriate Sample Matrix for the Measurement of Circulating Calretinin, a Biomarker for Mesothelioma-A Proof-Of-Concept Study.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicrosampling using filter cards for dried blood spots (DBS) and dried plasma spots (DPS) is a well-established technique offering practical advantages for blood collection and subsequent processing. For DBS/DPS, only a small sample volume is required it enables transport and storage at ambient temperature, and it is well suited for decentralized sample collections and resource-limited settings, as well as collection from elderly individuals, when venous blood collection might be problematic. Many protein-based biomarker assays like enzyme-linked immunosorbent assays (ELISA) depend on blood, plasma, or serum as sample matrix. Calretinin is an established biomarker for the early detection of mesothelioma. Herein, we investigated whether DPS are suitable for the determination of calretinin protein by ELISA in comparison to commonly used plasma samples.
methodsPlasma samples of 47 mesothelioma patients and 47 matched asbestos-exposed controls were spotted onto filter cards. After drying, calretinin was reconstituted and determined using ELISA.
resultsIt was revealed that the use of filter cards, i.e., DPS as sample matrix, was comparable to and in good agreement with the use of plasma. Calretinin could be determined reliably and comparably even after storage for 5 days at ambient temperature. Additionally, the performance of calretinin as biomarker using DPS is improved in comparison to the use of plasma, resulting in a slightly increased sensitivity at constant specificity.
conclusionThe findings of this proof-of-concept study suggest that filter cards represent a valuable alternative sampling method to determine calretinin for the detection or monitoring of mesothelioma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.